Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study

Roche is paying Hansoh $400 million up front in a broad deal involving several ADCs. Elsewhere, another top investor formed a China-focused fund and Ultragenyx sold a second review voucher.